The Peptide Report
DSIP nasal spray sits in a nuanced regulatory category in 2026 — not FDA-approved as a finished consumer product, but legally accessible through specific pathways. Here's what U.S. buyers need to verify before purchasing.
DSIP nasal spray occupies a nuanced regulatory space in 2026 — not an FDA-approved drug, but legally accessible through specific pathways. Here's what U.S. buyers need to know about safe, compliant access.
A citation-ready 2026 guide to the legal status of DSIP nasal spray in the United States. Learn how FDA classification, distribution pathways, and provider verification work — and what buyers should check before purchasing.
